Scinai Immunotherapeutics Ltd. SCNI US Equity
$2.51
-0.17 (-6.34%)
USD · as of 2026-08-28 · marketstack
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), an SEC filer in Biological Products, (No Diagnostic Substances), closed at $2.51, -6.3%, on 2026-08-28, with a market cap of $3.7B as of 2026-08-27, a return on equity of -91.9% and a net margin of -633.6%. Institutional ownership, earnings history and filed financials are on the tabs below.
Short interest· FINRA consolidated · settlement 2026-08-14
6 settlement cycles| Shares short | 70K |
| % of shares out | 0.0% |
| Days to cover | 1.0 |
| Δ vs 2026-07-31 | +51.2% |
bars = shares short · line = days to cover (own scale)
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.